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1. INTRODUCTION 
 
1.1. Physiology of preocular tear film 
 
The ocular surface including the cornea and conjunctiva and its overlying tear film is 
the first barrier of the eye to interact with the external environment. The human tear film coats 
the anterior surface of the eye, and is composed of three distinct layers: an inner mucin 
coating, a middle aqueous component, and a lipid overlay. It plays role in the inhibition of 
ocular surface invasion by pathogens, provides the air-tissue interface for gas exchange, and 
supplies essential nutrients and metabolites to maintain the integrity of the cornea. The 
complex tear film is secreted by the lacrimal functional unit which is composed of the ocular 
surface tissues, the main and accessory LGs, conjunctival goblet cells, the Meibomian glands 
and their interconnecting sensory and autonomic innervation. Dysfunction of these structures 
results in the loss of tear film homeostasis required in ocular surface maintenance and health. 
The lack of appropriate tear production may result in dry eye and the potential for significant 
surface pathology [1, 2].  
The outermost portion the tear film is the lipid layer, which is secreted by the 
Meibomian glands, Zeiss and Moll glands. This layer contains low and high polarity of lipids 
and prevents evaporation and overflow of the tear fluid. The main contributor of the mid, 
aqueous layer is the LG, but corneal and conjunctival epithelial cells also contribute in its 
production. This layer constitutes the bulk of the tear film, consists of inorganic salts, glucose, 
urea, enzymes, proteins, glycoproteins, electrolytes, and water, provides oxygen to the corneal 
epithelium, washes away debris and foreign particles and contains antibacterial lysozyme. The 
innermost layer of the tear film is the mucous layer, which consists of membrane associated 
and secreted mucins, electrolytes, and water. The mucin component is produced mainly but 
not exclusively by the conjunctival goblet cells, but small amount of solubile mucins are 
secreted by the LG. The mucin layer lubricates the ocular and palpebral surface and serves to 
protect the cornea and conjunctiva against the abrasive effects during the blink [3, 4]. 
 
1.2. Physiology of lacrimal gland 
 
LG contributes to the production of tear with several components. This process is 
mediated by an array of ion transporters/channels. More detailed understanding of the 
6 
 
physiology and pathophysiology of LG can lead us to find potencial pharmacological targets 
of dry eye disease. 
 LG is a tubuloacinar exocrine gland similar to other exocrine glands of the body such 
as the mammary gland, salivary gland and pancreas. The gland is composed of lobules 
separated by loose connective tissue. Such as other exocrine tubuloacinar glands, LG is 
composed mainly of three types of cells: acinar, ductal and myoepithelial cells. Acinar cell is 
the predominant cell type giving approximately 80% of all cells in the gland. These cells form 
the secretory unit of the gland termed as acinus. Duct cells make up to 15% of all cells in LG 
forming the duct system and modify the secretory product as it moves through the ducts. 
Similarly to acinar cells, duct cells are joined by tight junctions creating polarized cells that 
contribute to the unidirectional secretion of LG fluid. Myoepithelial cells are basket-shaped 
cells that surround the acinar cells and help to forward secreta in the ductal tree. 
 LG is innervated by both myelinated and unmyelinated fibers arising from the 
trigeminal nerve, the facial nerve, and from the superior cervical ganglion. Sympathetic 
nerves travel with the lacrimal artery along with parasympathetics in the zygomatic nerve. 
The efferent pathway originates with parasympathetic fibers from the superior salivary 
nucleus of the pons, which exit the brain stem with the facial nerve [1]. 
 LG is innervated by both the parasympathetic and sympathetic nerves. The 
parasympathetic system predominates both anatomically and functionally. The major 
neurotransmitters that regulate secretion are the parasympathetic neurotransmitters 
acetylcholine and VIP. Anticholinergic drugs (for example tolterodine, atropine, oxybutyrin, 
tiotropium, and hyoscine butylbromide) or drugs with anticholinergic side effects, such as 
tricyclic antidepressants and antihistamines, are known to cause dry eye in humans, serving as 
indirect evidence for the dominant cholinergic stimulation of the LG. [5] In addition to the 
cholinergic agonist acetylcholine that activates M3 muscarinic receptors, parasympathetic 
nerves release VIP as an important regulator of tear production in humans. [6]. Sympathetic 
nerves release norepinephrine that can activate α- and β-adrenergic signaling pathways. 
 
1.3.  Role of LG ducts in lacrimal secretion 
 
Acinar cell functions are widely studied, resulting in broad spectrum of information, 
however much less is known about the possible secretory function of duct cells. Although 
acini are the determining structures of tear production, the secretory role of ducts beside their 
piping function was also suspected for a long while. In 1972, Alexander and coworkers were 
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among the first pioneers who proposed the potential role of duct system in LG secretion. By 
using micropuncture and catheterization technique they suspected that the final fluid that 
reaches the ocular surface has a much higher K
+
 and Cl
-
 composition compared to the primary 
fluids. They suggested that LG duct system plays an important role by modifying the 
compositions of the primary LG acinar fluids [7]. These data appeared to suggest that tears 
are formed in two distinct stages: the plasma-like primary fluid formed by acinar cells is 
modified by duct cells during its transit in the duct lumen.  
Modifications of K
+
 and Cl
-
 content of primary acinar fluid by ductal secretory 
processes were also proposed in 1981. Dartt and colleagues found high Na
+
/K
+
 ATP-ase 
density in LG duct cells by using auto-radiographic method. Electron microscopy could detect 
secretory vesicles in the duct cells, suggesting the notion that their role is not limited to ion 
and water -, but also in protein secretion [8]. However, the role of LG duct epithelium on 
fluid, electrolyte, and protein secretion was not well understood at that time. 
Two new methods have been published to study LG duct epithelium during the past 
decade. Ubels and colleagues introduced the laser capture microdissection technique in LG 
research to perform gene expression studies on collected duct cells from frozen rat LG 
sections [9]. The first experimental model for the investigation of lacrimal duct function was 
adapted and applied by our group. Preparation of isolated intact LG ducts enabled the 
performance of real-time functional experiments on LG ducts for the first time. Role and 
regulation of various ion transporters in lacrimal duct can be studied with the use of these 
isolated, short-term cultured duct segments [10]. With the use of isolated duct segments, we 
started to investigate LG duct functions in the last few years. By a video-microscopic 
technique adapted and used for the first time in lacrimal duct research we investigate fluid 
secretion of isolated LG duct segments [11]. This technique was originally developed by 
Fernandez-Salazar and colleagues for the measurement of fluid secretion of pancreatic ducts 
[12]. Our previous experimental results gave evidence of the active role of the duct LG 
system in lacrimal fluid secretion.  
Although earlier reports demonstrated the contribution of VIP released by 
parasympathetic nerves in acinar protein secretion, its impact on the fluid secretion of the LG 
ducts remained unknown. VIP has been discovered as a smooth-muscle-relaxant, vasodilator 
peptide in the lung [13], but it is also an important regulator of tear production in humans. 
This was illustrated by a case report of a patient who had a VIP secreting metastatic 
pancreatic adenocarcinoma. With an eightyfold elevated serum VIP level, this individual had 
an increased tear volume and decreased tear osmolarity compared to age-matched controls, 
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indicating that VIP increases tear production in humans, most likely by stimulating LG fluid 
secretion [6]. VIP binds to class II seven transmembrane spanning domain GPCR as VPAC1 
and VPAC2 on the basolateral membrane of epithelial cells [14]. The VIP receptor interaction 
activates the G protein Gsα that stimulates adenylyl cyclase, that increases intracellular cAMP 
level. CAMP in turn activates PKA that stimulates secretion by phosphorylating target 
proteins. Hodges and coworkers suggested that most, but not all of VIP-stimulated protein 
secretion is cAMP dependent. Using a myristoylated PKA peptide inhibitor (PKI) based on 
the pseudosubstrate of PKA, VIP stimulated protein secretion was shown to be inhibited by 
about 70% [15]. 
Hormones and neurotransmitters, such as VIP, which raise cellular cAMP level, can 
stimulate acute CFTR channel activity. Our findings - based on indirect evidences - strongly 
suggested the role of CFTR in ductal fluid secretion as forskolin - a well-known activator of 
CFTR via the elevation of cytosolic cAMP levels – resulted in a significant swelling response 
in our experimental setup. CFTR has been shown to play a critical role in exocrine glands, 
such as pancreas, salivary, sweat glands and airways epithelium [16-21]. Furthermore, there 
are several clinical data about dry eye disease with various severity seen in CF patients, which 
implies the potential influence of CFTR in altered tear secretion [22-24]. Accumulating 
evidences from gene expression studies performed on rat and rabbit LGs demonstrated the 
predominant expression of CFTR in LG duct cells [9, 25, 26]. The main role of the CFTR is a 
regulated anion conductance in the apical membrane of many different epithelial cell types. 
Regulation of channel activity is predominantly via cAMP/PKA signaling [27]. The PKA-
dependent phosphorylation of the CFTR protein being required for channel activity [28]. 
Availability of transgenic mouse models carrying genetic defects in CFTR allows us the direct 
examination of its role in LG [29-31]. 
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2. AIMS OF THE STUDY 
 
 LG is the major source of tears that bathe the ocular surface and its secretion is 
dominantly mediated by the neurotransmitters released by the parasympathetic nerves, like 
acetylcholine and VIP. Although earlier reports demonstrated the presence of cholinergic and 
VIP receptors on LG cells and also their contribution in acinar protein secretion, the impact of 
parasympathetic transmitters on the fluid secretion of LG ducts is completely unknown. 
Therefore we aimed to investigate the role of parasympathetic stimulation induced by 
cholinomimetic compound carbachol or VIP on LG duct function in mouse.  
 CFTR plays a critical role in the transmembrane transport of chloride in many 
secretory epithelia. There are accumulating evidences that VIP stimulation and CFTR 
functions are tightly related and regulated. Therefore investigation of the role of CFTR in the 
parasympathetic secretory machinery in mouse LG ducts was also aimed. 
 
 
Our specific aims were: 
 
 To explore the role of cholinergic stimulation on fluid secretion in LG ducts isolated 
from WT and CFTR KO mice. 
 To investigate fluid secretion of isolated LG duct segments evoked by VIP in WT and 
CFTR KO LG ducts. 
 To investigate the Ca2+ homeostasis underlying carbachol and VIP stimulation both in 
WT and CFTR KO LG ducts. 
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3. MATERIALS AND METHODS 
 
3.1. Animals 
 
CFTR KO mice used throughout our studies were originally generated by Ratcliff et 
al. and was provided as a gift from Ursula Seidler (Hannover Medical School, Hannover, 
Germany) [30, 31]. The mice were congenic on the FVB/N background. A hypoxanthine 
phosphoribosil transferase insertion introduces a termination codon in frame with the cftr 
coding sequence to terminate prematurely the CFTR protein. No functional CFTR protein is 
expressed by the CFTR KO mice. Genotyping was performed by RT-PCR. The animals were 
kept at a constant room temperature of 24°C with a 12 h light–dark cycle and were allowed 
free access to specific fiber-free CFTR chow (C1013, Altromin, Lage, Germany) and drinking 
solution containing PEG (23 g/l PEG 4000) and high HCO
3−
 (in mM: 40 Na2SO4, 75 
NaHCO3, 10 NaCl, 10 KCl). The mice were kept in the Animal Facility of the First 
Department of Medicine, University of Szeged. All mice were genotyped prior to the 
experiments. WT refers to the +/+ littermates of the CFTR KO mice. The mice used in this 
study were 8-24 weeks old and weigh of 14-24 g (depending on the genotype and age). 
Gender ratio was 1:1 for all groups. Animals were narcotized intraperitoneally with ketamine 
(80 mg/kg) and xylazine (10 mg/kg) and euthanized with pentobarbital overdose (100 mg/kg). 
All experiments were conducted in compliance with the ARVO Statement for the Use 
of Animals in Ophthalmic and Vision Research. The protocol has been approved by the 
Ethical Committee for the Protection of Animals in Research of the University of Szeged, 
Szeged, Hungary and conformed to the Directive 2010/63/EU of the European Parliament. 
 
3.2. Solutions and chemicals 
 
DMEM supplemented with 100 U/ml collagenase (Worthington Lakewood, NJ, USA) 
and 1 mg/ml bovine serum albumin was used as isolation solution. Storage solution contained 
DMEM and 3% (wt/vol) bovine serum albumin. Culture solution contained McCoy’s 5A 
tissue culture medium, 10% (vol/vol) fetal calf serum, and 2 mM glutamine. Media 
supplements (DMEM, McCoy, FCS, glutamine and BSA) were purchased from Sigma-
Aldrich (Budapest, Hungary).  
Carbachol (carbamoylcholine chloride) and VIP were purchased from Sigma-Aldrich 
(Budapest, Hungary). Composition of solutions used in our studies is summarized in Table 1. 
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All chemicals listed in Table 1 were purchased form Sigma-Aldrich (Budapest, Hungary). 
The pH of standard HEPES-buffered solution was set to 7.4 with HCl at 37 °C. The standard 
HCO3
–
/CO2 buffered solution was gassed with 95% O2/5% CO2 at 37 °C. FURA2-AM was 
purchased from Invitrogen (Waltham, MA, USA). 
 
 
 
  Content of Solutions 
Compound 
HEPES 
buffered 
solution 
HCO3
-
 /CO2
-
 
buffered 
solution 
Isolation 
solution 
Storage 
solution 
Culture 
solution 
NaCl (mM) 140 115 
   KCl (mM) 5 5 
   Na-HEPES (mM) 10 
 
   MgCl2 (mM) 1 1 
   CaCl2 (mM) 2 1 
   D-Glucose (mM) 10 10 
   NaHCO3 (mM) 
 
25 
   Dulbecco Modified Eagle Medium 
  
X X 
 
Collagenase (U/ml) 
  
100 
  
Bovine serum albumin (mg/ml) 
  
1 0,03 
 
McCoy’s 5A Tissue Culture Medium 
  
  
X 
Fetal calf serum, (vol/vol %) 
  
  
10 
Glutamine (mM)       2 
 
Table 1:  Composition of solutions 
 
 
3.3. H&E staining 
 
Freshly dissected LG tissues from both WT and KO mice were fixed in 4% buffered 
formaldehyde and embedded in paraffin. Then 3.5 μm thick serial sections were cut and 
stained with H&E. 
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3.4. Immunofluorescence  
 
Fifteen μm thick cryostat sections were rehydrated by washing in TBS (20 mM Tris-
HCl pH: 7.5, 150 mM NaCl) for 5 min, then fixed in 2% PFA. After washing the sections in 
TBS three times for 5 min each, the samples were permeabilized with 0,1% Triton-X in TBS 
for 10 to 15 min. The sections were blocked with 5% FCS in TBS for 1 hour at room 
temperature followed by an overnight incubation with primary antibodies for CFTR (1:100, 
Alomone Labs, Jerusalem, Israel), for VPAC1 (1:1000) or VPAC2 (1:250, Abcam, 
Cambridge, UK). Next day the samples were incubated with secondary antibody, Alexa-488 
conjugated goat anti-rabbit (1:1000, Abcam, Cambridge, UK) for 1 hour and Hoechst 
(1:1000, Sigma-Aldrich) for 20 minutes at room temperature. The samples were examined 
under a Zeiss LSM 880 confocal laser scanning microscope (Oberkochen, Germany). Images 
were analyzed with ImageJ (NIH). 
 
3.5. Isolation and culture of lacrimal duct segments 
 
Mouse LG interlobular ducts were isolated as previously described by our laboratory 
[10]. Briefly, LGs were dissected and transferred to a sterile small flat-bottom glass flask 
containing a cold (4 °C) storage solution. Isolation solution was injected into the interstitium 
of the glands and the tissue pieces were transferred to a glass flask containing 2 ml of 
isolation solution. Following a 25 min incubation period in a shaking water bath at 37 °C, 
isolation solution was removed and 5 ml of fresh cold storage (4 °C) solution was added to 
the flask. LG tissue samples were transferred to a glass microscope slide and viewed under 
stereo microscope. Following microdissection of interlobular and intralobular LG ducts, intact 
LG ducts were transferred to the culture solution in a Petri dish. Isolated ducts were cultured 
overnight in a 37 °C incubator gassed with 5 % CO2. 
 
3.6. Measurement of ductal fluid secretion 
 
Videomicroscopic technique was used for the measurement of duct fluid secretion. 
The method was originally developed for the measurement of pancreatic duct fluid secretion 
and was modified by our laboratory for the investigation of LG duct secretion [11, 12]. Fluid 
secretion of LG ducts was analyzed using the swelling method. Ends of isolated LG ducts seal 
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after overnight culture, forming a closed luminal space. Secretory process of the duct 
epithelium results in swelling of the ducts as the luminal space fills with the secreted fluid. 
The change in volume of duct lumen can be analyzed using video-microscopy.   
Cultured LG duct segments were carefully transferred to a coverslip pre-treated with 
Poli-l-lysine. The coverslip formed the base of a perfusion chamber mounted on an inverted 
microscope (Olympus Ltd., Budapest, Hungary). The chamber was perfused with solutions 
via an infusion pump at approximately 2.5 ml/min. The temperature of perfusion chamber was 
maintained at 37 °C. Ducts were visualized at high magnification (40 x objective). Bright-
field images were acquired at set time intervals (1 min in case of ductal fluid secretion 
experiments) using a charge-coupled device camera connected to a PC. Both the duration of 
experiments and the time intervals between images were defined in Xcellence software. An 
image series in TIFF-format was generated containing all of the collected data from the same 
experiment. Scion Image (Scion Corporation, Frederick, MD, USA) software was used to 
analyze changes to obtain values from the area corresponding to the luminal space in each 
image. The initial lumen length (L0) and the lumen area (A0) were measured directly from the 
pixel intensities on the first image. The lumen diameter was calculated assuming cylindrical 
setup of the duct, from the formula 2R=A0/L0. The luminal surface area was calculated as 
2πR0L0, also assuming cylindrical geometry. Measurements from subsequent individual 
images were normalized to the first lumen area in the series (A0) thus giving values for the 
relative area (AR=A/A0). Relative luminal volume (VR=V/V0) of the ducts was then 
calculated from the relative image area. These calculations were done using Scion Image and 
Microsoft Excel software.  
In fluid secretion measurements the investigated compounds were added to the 
perfusate after 10 min of superfusion with HEPES-buffered or HCO3
-
/CO2-buffered solution. 
Perfusion was changed to hypotonic solution for 5 min at the end of each experiment in order 
to confirm epithelial integrity. Complete sealing was proved by rapid swelling as a response 
to hypotonic challenge. Data obtained from ducts not showing swelling response were 
discarded. 
 
3.7. Measurement of [Ca2+]i 
 
[Ca
2+
]i was measured using Ca
2+
-sensitive fluorescent dye FURA 2AM (4–5 μM) as 
described earlier [10]. Changes in [Ca
2+
]i were measured using an imaging system (Xcellence; 
Olympus, Budapest, Hungary). Four to 5 small areas (ROIs) of 5 to 10 cells were excited in 
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each intact duct with light at 340 and 380 nm, and the 380/340 fluorescence emission ratio 
was measured at 510 nm. Results are expressed as maximum value of the 380/340 
fluorescence emission ratio [Fmax (380/340)]. One [Ca
2+
]i measurement was obtained per second. 
 
3.8. Statistics 
 
Kruskal-Wallis test with Dunn method was used for the analysis of tear secretion. A 
mixed ANOVA model was applied for the calculation of ductal fluid secretion. Effects of the 
stimulatory compounds (VIP or carbachol) were taken into account as ˝fixed effects˝. The 
effect of the individual ˝duct˝ and the ˝duct and effects of VIP or carbachol˝ interaction (we 
assumed that the value of the effect of the stimulatory compounds depend on the individual 
duct) were taken into account as random effects in the model. Statistical software (SigmaPlot 
Systat; Software, Inc., London, UK) was used to analyze the data, which were presented as 
means ± SEM. A value of P < 0.05 was regarded as significant. 
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4. RESULTS 
 
4.1. H&E staining of LGs from WT and CFTR KO mice 
 
 The morphologic differences between LGs originated from KO and WT mice were 
investigated by H&E staining. Freshly dissected LGs of 8 – 10 and 20 – 24 week-old animals 
were processed. No obvious structural changes have been observed in KO LG tissues as 
compared to their age-matched WT counterparts. Figure 1 shows demonstrative images of 
H&E staining of LG from WT and KO mice. 
 
 
 
Figure 1: H&E staining of LG tissues from WT and CFTR KO mice. There are no significant 
morphologic changes of the KO LGs, including ducts (arrowheads) and acinar cells (arrows) 
compared to WT tissues. 
 
4.2. Immunofluorescence 
 
 Immunofluorescence was used to confirm the presence of VPAC1, VPAC2 receptors 
and CFTR in mouse LG duct cells. We proved the presence of CFTR protein most 
prominently in the apical membranes of LG duct cells from WT animals, although some 
diffuse staining was also found in acinar cells, mostly within the cytoplasm. As anticipated, 
we were unable to detect the presence of CFTR protein in LGs originated from KO mice 
(Figure 2).  
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Figure 2: Immunofluorescence staining of CFTR in LG tissues from WT and CFTR KO mice. CFTR 
staining was most intense in the apical membranes of duct cells (d), compared to acinar cells (ac). No 
staining could be observed in LGs from KO mice. Hoechst was used to stain nuclei as blue. 
 
 VPAC1 is dominant in the duct cells as demonstrated in Figure 3. 
Immunofluorescence staining of VPAC1 receptors revealed a mosaic pattern in the expression 
of the receptor proteins. Intensity of fluorescence varied excessively in the investigated duct 
segments from the intense immunofluorescence to the lack of staining. No difference was 
detected in the immunoreactivity between LG tissues of WT and KO mice. 
Intense VPAC2 staining was detected not only in the duct cells but also in the 
basolateral surface of the acinar cells (Figure 3). Intensity of immunofluorescence staining 
was similar in case of both WT and KO mice. 
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Figure 3: Immunofluorescence staining of VPAC1 and VPAC2  receptors in LGs of WT and KO 
mice. VPAC1 staining was more intense in ducts (d) than acinar (ac) cells. We observed VPAC2 in 
the basolateral surface of both duct (d) and acinar (ac) cells. There were no significant differences 
between WT and KO samples in case of both VPAC1 and VPAC2 receptors. Hoechst was used to 
stain nuclei as blue. 
 
4.3. Cholinergic-stimulated fluid secretion in isolated LG ducts 
 
 To investigate the role of CFTR in cholinergic-evoked ductal fluid secretion, the 
responses to muscarinic agonist carbachol were examined in WT and KO LG ducts both in 
HEPES and HCO3
-
/CO2--buffered solution.  Duct segments were isolated from 14 to 24-week-
old mice. Rapid secretion could be observed in the first 4-5 minutes of carbachol stimulation 
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(100 µM) followed by a slower phase in HEPES buffered solution (secretory rates in the first 
10 minutes of stimulation were: 134±5 pl/min/mm2 in WT ducts, and 133±6 pl/min/mm2 in 
KO ducts). Carbachol-evoked fluid secretory rates observed in WT and in KO ducts did not 
differ significantly in HEPES-buffered solution.  
Carbachol-evoked fluid secretion in WT and in KO ducts superfused with HCO3
-
/CO2-
-buffered solution was then investigated. Similarly to the results obtained in HEPES buffer a 
rapid secretory effect could be detected in the first 4-5 min both in WT and in KO ducts 
followed by slower secretion (secretory rates in the first 10 minutes of stimulation were: 
133±6 pl/min/mm2; in WT ducts; and 130±5 pl/min/mm2 in KO ducts). Carbachol-evoked 
fluid secretion observed in WT and in KO ducts did not differ significantly in HCO3
-
/CO2--
buffered solution.  
Briefly, carbachol stimulated fluid secretion in a similar manner both in WT and KO 
ducts and both in HEPES and HCO3
-
/CO2--buffered solutions. There was not significant 
difference observed in secretory rates either between WT and KO ducts or between different 
buffers. Figure 4 and 5 demonstrate the carbachol-induced luminal volume changes in WT 
and KO ducts observed in HCO3
-
/CO2--buffered solution.  
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Figure 4: Effect of carbachol on ductal fluid secretion in LG ducts isolated from WT and CFTR KO 
mice. (A) WT ducts were exposed either to 100 μM carbachol (filled rhombus) or to no agonist (empty 
triangle). (B) KO ducts were exposed either to 100 μM carbachol (filled square) or to no agonist 
(empty triangle). Changes in relative lumial volume (Vr) are presented. Data were collected from 6 
ducts isolated from 3 different animals in each series and are presented as means ±SEM.  
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Figure 5: Demonstrative photo series of secreting isolated LG duct segments in response to carbachol 
stimulation. The luminal spaces of the native images (first and third rows) are marked with blue color 
(second and forth rows). 
 
 
4.4. VIP-induced fluid secretion in isolated LG ducts 
 
Effect of VIP (100 nM) on ductal fluid secretion was investigated on both WT and 
CFTR KO mouse LG ducts. These experiments were performed exclusively in HCO3
-
/CO2--
buffered solutions. Motives of solely HCO3
-
/CO2 buffered experiments were partly the 
identical results obtained in different (HEPES and HCO3
-
/CO2-) buffered solution in our 
previous experiments performed on different species. These results are displayed in the 
previous section and in our earlier publications. Furthermore, our VIP experiments were 
restricted to the HCO3
-
/CO2 buffered solutions because of the difficulties observed during our 
VIP-stimulated fluid secretion experiments. In these experiments remarkable portion of 
isolated ducts missed to react to the applied agent. These findings are in accordance with our 
results in VPAC1 immunofluorescence studies where the expression of the receptor protein 
showed a mosaic pattern and the fluctuation of the presence of VPAC1 predicted an 
excessively altering response of the different duct segments to VIP stimulation. Obviously, all 
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data displayed in this section were obtained from the reacting (ie. responding with a swelling 
reaction) ducts.       
VIP stimulation resulted in a robust and continuous fluid secretory response in isolated 
LG duct segments originated from WT mice (secretory rates in the first 10 minutes of 
stimulation were: 213.1±37.3 pl/min/mm2, n=7). In contrast, CFTR KO ducts exhibited only a 
very weak pulse-like secretion in the first 5 minutes of stimulation (54.5±18.4 pl/min/mm2, 
n=6), followed by a plateau (Figure 6). VIP-induced luminal volume changes in WT and KO 
ducts observed during videomicroscopic experiments demonstrated in Figure 7. 
 
 
 
 
 
Figure 6: Effect of VIP stimulation on ductal fluid secretion in isolated LG ducts originated from WT 
and CFTR KO mice. (A) WT ducts were exposed either to 100 nM VIP (filled rhombus) or to no 
agonist (empty triangle). (B) CFTR KO ducts were exposed either to 100 nM VIP (filled square) or to 
no agonist (empty triangle). Changes in relative lumial volume (Vr) are presented. Data were obtained 
from 6 ducts isolated from 3 different animals in each series and are presented as means ±SEM. 
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Figure 7: Demonstrative photo series of secreting isolated LG duct segments in response to VIP 
stimulation. The luminal spaces of the native images (first and third rows) are marked with blue color 
(second and forth rows). 
 
 
4.5. Carbachol and VIP-induced Ca2+ signaling of isolated LG ducts 
 
To investigate the effect of carbachol and the potential difference in [Ca
2+
]i  between 
WT and KO ducts, carbachol-evoked elevation of [Ca
2+
]i was measured in both groups of 
isolated ducts. [Ca
2+
]i was elevated by carbachol in a dose dependent manner both in WT 
(Fmax(380/340): 1 μM: 1.19±0.01; 10 μM: 1.67±0.05; 100 μM: 1.76±0.05) and in KO duct cells 
(Fmax(380/340): 1 μM: 1.15±0.02; 10 μM: 1.48±0.03; 100 μM: 1.83±0.05). Concentrations of 
carbachol over 100 μM proved to be citotoxic and therefore were excluded from our further 
experiments. No significant differences between WT and KO ducts were observed in these 
experiments (Figure 8). 
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Figure 8: Effects of carbachol on [Ca
2+
]i in LG duct cells from WT and KO mice. (A) Representative 
recordings of the microfluorescence experiments. (B) Carbachol dose-dependently elevated the [Ca
2+
]i, 
although no significant differences were found in the responses between ducts from WT and KO 
animals. F380/340: 380/340 nm fluorescence emission ratio; Fmax(380/340): maximum value of the 380/340 
nm fluorescence emission ratio. 
 
 
Intracellular Ca
2+
 homeostasis underlying VIP stimulation was measured both in WT 
and in CFTR KO duct segments (Figure 9). Concentration of VIP was 100 nM in these 
experiments. This value was based on data from the literature and on our preliminary 
experiments where application of higher concentrations of VIP (200 and 500 nM) did not 
result in greater effects compared to the 100 nM concentration. VIP stimulation (100 nM) 
resulted in a small, but statistically significant increase in [Ca
2+
]i both in WT (11.6±0.7%, 
p=0.001) and in CFTR KO ducts (11.1±0.5%, p=0.002). Cholinergic agonist carbachol (100 
mM) was used as positive control in these experiments. 
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Figure 9: Effects of VIP and carbachol on [Ca
2+
]i  in LG duct cells from WT and KO mice. A) 
Representative recordings of the microfluorescence experiments: effects of VIP (100 nM) on [Ca
2+
]i in 
LG duct cells from WT and KO mice (A, left curve). Carbachol (100 µM) was used for comparison - 
as a positive control - in these experiments (A, right curve). B) Maximum values of the 380/340 nm 
fluorescence emission ratios. F380/340: 380/340 nm fluorescence emission ratio; Fmax(380/340): maximum 
value of the 380/340 nm fluorescence emission ratio. 
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5. DISCUSSION 
 
 Dry eye disease is an increasing health care problem in the industrialized countries 
affecting millions of people worldwide [32]. It has a deep impact on the patients’quality of 
life and induces a permanently increasing health care problem. Despite its growing economic 
effects, treatment options of the disease are limited.  The management of the disease is a 
complex process but most of the available treatments focus on the alleviation of ocular 
symptoms, without targeting its underlying cause. Presently substitution of tear fluid with 
arteficial tear drops and – in severe cases – anti-inflammatory treatment of the ocular surface 
are the main but mostly insufficient interventions [33-35]. Appropriate amount of balanced 
electrolyte, protein and mucin composition of fluid secreted by the LG is fundamental for 
maintaining preocular tear film volume and integrity [1, 36]. Our understanding of the 
physiological and pathological mechanisms of LG secretion is limited, despite its critical 
importance in developing new treatment strategies. More detailed understanding of LG 
function is therefore essential in order to develop novel pharmacological approaches in the 
treatment of dry eye disease [7]. Unfortunately, duct cells have been understudied for many 
years compared to the widely investigated acinar cells. In the last decade, however, gene 
expression studies suggested the secretory role of LG duct epithelial cells, since greater 
expression of wide range of transmembrane transporters could be demonstrated in the duct 
cells compared to acinar cells [25, 37-41]. Although these results were important steps toward 
the clarification of duct cell function, they were unable to provide direct functional results. 
Our laboratory developed the first experimental model suitable for the investigation of 
lacrimal duct function, which opened a new way in lacrimal duct research. Our efforts are 
directed toward the clarification of the role of LG ducts in the secretory process of the gland 
using this isolated duct model [11,12] These viable duct segments are appropriate 
models not only for the investigation of the function of transmembrane transporters, but also 
for the investigation of the regulation of secretory machinery. Although secretory process of 
duct epithelium may play an important role in tear production, our knowledge about the 
regulation of LG duct function is rather limited. LG duct secretion is mediated by both 
parasympathetic and sympathetic systems [5,42,43]. The anatomically and functionally 
predominant parasympathetic nerves can be subdivided into two different branches based on 
the secreted neurotransmitters. Cholinergic nerve endings release the cholinergic agonist 
acetylcholine, while VIP-ergic nerve terminals produce VIP. Both neurotransmitters have 
26 
 
major effects on LG secretion [44]. The available experimental evidences about the role of the 
paraysmpathetic system in LG fluid secretion are solely from intact LGs or acini. We 
investigated the direct effect of the cholinergic and VIP-ergic stimuli on isolated LG duct 
segments, and explored the relationship between the CFTR chloride channel and the 
parasympathetic regulatory system. Transgenic mouse models carrying genetic defects in 
CFTR made it possible to set up experiments for investigating its role in fluid secretion and to 
shed light on the potential morphological alterations caused by the missing CFTR protein.
 To assess the potential morphologic differences between LGs from CFTR KO and WT 
mice, histological examinations were performed on freshly dissected LGs. H&E staining 
revealed no obvious structural changes in CFTR KO LG tissues including ducts as compared 
to their age-matched WT counterparts. These results demonstrated that functional failure may 
present before morphological alterations during the course of disease progression. However, 
investigation of the morphological alterations in later stages of the disease in CFTR KO mice 
has strong limitations as shorter life expectancies of CFTR KO mice. Further studies are 
needed in order to clarify potential alterations in LG morphology later in life. In a case report 
of a CF patient, Alghadyan and colleagues observed increased number and size of vacuoles 
and a definite decrease in the number of the acini. They supposed that thickened mucus can 
occlude small ducts within the LG resulting in the degeneration of the acini and the 
appearance of vacuoles [45]. 
 Immunofluorescence was used to confirm the presence and localization of CFTR, 
VPAC1 and VPAC2 proteins of mouse LG duct cells. Previous reports demonstrated the 
presence of CFTR mRNA and protein both in acinar and duct cells in rat and rabbit [9, 25, 
39]. As demonstrated in Figure 2, we could observe intense CFTR staining most 
characteristically in the apical membranes of LG duct cells from WT animals. Some 
substantially weaker diffuse staining was also found in acinar cells, mostly within the 
cytoplasm. Although the appearance of CFTR protein is undoubted in acinar cells of mouse 
LG, our immunostaining results pointed its predominant presence in duct cells. These results 
suggest the important and duct-specific function of CFTR in LG similarly to its role in 
pancreatic ducts [46,47]. According to our expectations CFTR protein was not detectable in 
LGs of CFTR KO mice.  
Presence and localization of VPAC1 and VPAC2 receptors was also investigated in 
LGs of both WT and CFTR KO mice. A previous report by Hodges et al. showed the presence 
of these receptors by immunostaining on the basolateral surface of both acinar and duct cells 
in rat [15]. An apparent difference was revealed in the distribution of VPAC1 and VPAC2 
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receptors in mouse LG in our study. Presence of VPAC1 was proved predominantly in ducts 
by immunoreactivity. Beside the characteristically ductal localization of VPAC1 receptors, a 
mosaic pattern in the expression of the receptor proteins was also revealed. Intensity of 
immunofluorescence varied excessively in the analyzed duct segments from the intense 
staining to the almost complete lack of demonstrability. VPAC2 showed a more homogeneous 
distribution in LG tissue: these receptors were traceable in both acinar and duct cells. Both 
VPAC1 and VPAC2 were observed most prominently on the basolateral membrane of mouse 
LG cells. Lack of CFTR did not influence the expression of VPAC1 and VPAC2 proteins: no 
difference was detected between the immunoreactivity of WT and CFTR KO LG tissues. 
 To explore the fluid secretory effect of parasympathetic neurotransmitters, 
videomicroscopic experiments were applied. Cholinergic agonist carbachol (100 µM) caused 
a biphasic fluid secretory response consisting of a rapid pulse-like secretion in the first 5 min, 
followed by a plateau. Similar secretory rates and patterns were observed in KO ducts, 
suggesting the independence of cholinergic activated secretory mechanisms from the presence 
of functionally active CFTR. VIP (100 nM) stimulation caused a strong and continuous fluid 
secretion in ducts from WT mice. In contrast, as a result of VIP stimulation, CFTR KO ducts 
exhibited only a weak pulse-like secretion in the first 5 min, followed by a plateau. The 
observed reduction in response to VIP stimulation in CFTR KO ducts may be explained by 
the lack of CFTR rather than changes of VPAC1 and VPAC2 since no difference was 
detected in the densitiy of VIP receptors between WT and CFTR KO ducts in our 
immunofluorescence studies. Role of CFTR can be explained by the following chain of 
effects: stimulation of VIP receptors increases the intracellular cAMP levels via adenylyl-
cyclase then cAMP - as a potent activator - increases the activity of CFTR. Therefore, this 
transporter seems to be the determining component of the robust fluid secretion evoked by 
VIP in WT ducts. The weak secretory response observed in CFTR KO ducts during VIP 
stimulation seems to confirm the described mechanism.   
 Ca
2+
 homeostasis underlying parasympathetic stimulation and the potential role of 
CFTR protein was also investigated. The effect of carbachol and VIP stimuli on the cytosolic 
Ca
2+
 signaling was measured by microfluorometry. Carbachol induced a dose-dependent 
elevation of [Ca
2+
]i in both WT and KO duct cells. The carbachol-evoked response of 
cytosolic Ca
2+
 level changes in WT and CFTR KO ducts did not differ significantly. The 
unchanged carbachol-evoked elevation of [Ca
2+
]i in parallel with the unchanged carbachol-
evoked secretory response in CFTR KO duct cells suggests the determining or exclusive role 
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of Ca
2+
 signaling in cholinergic stimulation and excludes the considerable function of CFTR 
in this pathway.  
VIP also acts not only through the adenylyl cyclase-cAMP system but – in a smaller 
extent – it also elevated [Ca2+]i . VIP-evoked elevations of [Ca
2+
]i were also independent from 
the presence of CFTR and did not differ in WT and CFTR KO LG ducts in a significant 
manner. However, elevations of [Ca
2+
]i had a much smaller extent in case of VIP stimulation 
compared to the carbachol effect. Our findings in immunostaining studies and in fluid 
secretion together with [Ca
2+
]i experiments suggests two, partially independent 
parasympathetic regulatory pathways. Briefly, carbachol stimulation acts solely through 
elevation of [Ca
2+
]i and it does not involve adenylyl cyclase-cAMP route. Consequently, 
CFTR is not involved in carbachol stimulated fluid secretion as it is activated by cAMP. For 
VIP stimuli [Ca
2+
]i was slightly elevated without significant difference between the values 
measured in WT and CFTR KO ducts. However, secretory response of LG ducts showed a 
great significant difference in WT and CFTR KO ducts: rate of fluid secretion of CFTR KO 
ducts was far below the value obtained in WT ducts. These data prove the determining role of 
adenylyl cyclase-cAMP-CFTR route in VIP-stimulated fluid secretion of LG ducts. Results of 
our VIP experiments are in accordance with previous observations that VIP acts 
predominantly through elevation of cytosolic cAMP level, the minority of its action thougt to 
be mediated by Ca
2+
 signaling [48-50]. Lack of functionally active CFTR seen in CFTR KO 
mice influences VIP-evoked secretory response of LG ducts and thus can modify the total 
parasympathetic-evoked secretory answer of the LGs. CFTR could influence LG secretion 
through the modification of ductal secretion and therefore defects in CFTR may significantly 
compromise Cl
-
 and water secretion from LG ducts. 
 
6. SUMMARY 
 In conclusion, our results presented here provide new proof of the secretory role of LG 
ducts beside their piping function. We demonstrated the functional presence of CFTR and 
VIP receptors in LG duct cells. Strong predominance of CFTR protein on the apical, VPAC1 
and VPAC2 on the basolateral surface of the duct cells was observed. Fluid secretory 
experiments provided direct functional evidence of the importance of parasympathetic 
regulation in LG ducts. The observed carbachol- and VIP-induced significant fluid secretion 
suggests the importance of these secretagouges on the fluid secretion of the duct system. 
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We detected the elevation [Ca
2+
]i for the stimuli of carbachol an VIP, and the 
preservation of the Ca
2+
 signaling pathway in CFTR KO mice. These results reveal new 
insight into the role of VIP in LG function and confirm the connection between CFTR and 
VIP regulatory pathways. Further studies are needed to clarify whether modification of CFTR 
or VIP function may serve as a potential target to stimulate LG secretion and therefore can be 
an option in treating aqueous deficient dry eye. 
 
Conclusions of the studies on LG ducts presented in the thesis are:  
1. CFTR is dominantly expressed on the apical membrane of the LG duct cells 
compared to acinar cells in mice 
2. VPAC1 receptors are expressed predominantly in the duct cells, while VPAC2 
receptors are expressed in both duct and acinar cells in mice LG.  VPAC1 and 
VPAC2 receptors are located on the basolateral membranes. 
3. For the first time in LG research, CFTR KO mice were used to study the role of 
parasympathetic regulation in LG duct function and to study the role of CFTR in 
the parasympathetic secretory machinery 
4. Using our isolated duct segment model developed earlier, fluid secretion of LG 
ducts from WT and CFTR KO mice was investigated by videomicroscopic 
methods. Significant fluid secretion was observed as a result of carbachol and 
VIP stimulation. 
5. The significant secretory response of LG ducts from KO mice for carbachol 
stimuli showed the independence of cholinergic activated secretory mechanisms 
from the presence of functionally active CFTR. 
6. Role of CFTR in the VIP-induced secretory process found to be decisive as only 
small VIP-induced fluid secretion was detected in the absence of CFTR protein. 
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7. Similar elevations of [Ca2+]i levels in WT and KO ducts - both in case of 
carbachol and VIP stimuli - demonstrated the independence of [Ca
2+
]i 
homeostasis from the functionally active CFTR. 
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